First, Nox2 deficiency reduces myocardial oxidative stress, attenuates decreased catecholaminergic histofluorescence profiles, and restores protein expression levels of PGP9.5, GAP43, tyrosine hydroxylase and NET in doxorubicin-induced heart failure. Here, UCHL1 is linked to heart failure.